Richmond Pharmacology’s London Bridge Unit is now officially an ILS Resuscitation Council Course Centre.

The exciting news means we can now officially train staff and external candidates in Immediate Life Support. The status continues Richmond Pharmacology’s commitment to the highest safety standards internally, but also support other Phase one facilities and hospitals in providing ILS training.  Our internal training has already begun with David Applegate, Kumi Takami, and Mizuki Konno already passing there ILS Re-certification course .

Also pictured, Franklin Gordon, our Resuscitation Simulation & Clinical Skills Practitioner, Congratulations all round!

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event